title: Treatments for unwanted facial hair.
abstract: Twenty-two percent of women in North America have unwanted facial hair, which can cause embarrassment and result in a significant emotional burden. Treatment options include plucking, waxing (including the sugar forms), depilatories, bleaching, shaving, electrolysis, laser, intense pulsed light (IPL), and eflornithine 13.9% cream (Vaniqa, Barrier Therapeutics in Canada and Shire Pharmaceuticals elsewhere). Eflornithine 13.9% cream is a topical treatment that does not remove the hairs, but acts to reduce the rate of growth and appears to be effective for unwanted facial hair on the mustache and chin area. Eflornithine 13.9% cream can be used in combination with other treatments such as lasers and IPL to give the patient the best chance for successful hair removal.
authors.affiliation: Hair Research and Treatment Centre, and Division of Dermatology, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Shapiro
authors.forename: H
authors.initials: H
authors.lastname: Lui
mesh_terms: D000287:Administration, Topical; D000518:Eflornithine / Q000008:administration & dosage / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D005145:Face; D005260:Female; D006204:Hair Removal / Q000379:methods*; D006628:Hirsutism / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D011085:Polycystic Ovary Syndrome / Q000150:complications
chemical_list: D004791:Enzyme Inhibitors; D000518:Eflornithine